The company is developing what it calls Sovaprevir, which is also known as ACH-1625.
http://www.thestreet.com/story/11970082/1/be-greedy-on-achillion-after-its-selloff.html
http://www.thestreet.com/story/11970082/1/be-greedy-on-achillion-after-its-selloff.html
No comments:
Post a Comment